Le guide intitulé « Autorisation d’accès précoce aux médicaments : doctrine d’évaluation de la HAS », ci-joint, est adopté.
eNrtWEtz2jAQvvMrGN/lFzRAx5BpadIy00wpCdNOL4yQFhAVlqMHkP76yhga6NhNY+JbLozRSrsr6dtvdxVdble8vgapmIi7TuD6Th1iIiiL511nfHeN2s5lrxYt8RofTWu5vhuETp1wrFTXSaXuFHCs3O83nz+AXQ/S6dXqkZgugeiTeUYz7n7CanGDk3ROPVoLRusr0AtBu05i9G60HiktrRe9jZA/VYIJRN5+5Fi6nDSPxyMvVfYfWo0C+RnH81ylM1lKJzFSQqz7WMNcyIdc1YmkwSTstC+CTruUEaZGoISRBIZYL4ZSrBkFmr8NzBWUMjLb0FuQaw46NZKr3FuSlSqlHC/xdgT3g3yn31lpX2818lHQaoX+RdDwWxcNv5QpeXRU+fCxm/CSSaPR9INm4M2kR4GwFOUoRqEfhsgPwo5HiadghahBYRvhtWQ8E9oBIjiHOSAKiGO0wEYDsj9CMr0bVDi2H4mQ2n4gTEWiU+125dzYm0Ms1kwbflikcCZGmBBQKJE2mEgq3KIVUEbwyiJMISpIugFrAcEac7NftfdBlUTWMPWSV4Qppvqn8VGRHQn3T2KXMpVw/OAuVVL2qLC0V6FBWharbiPpDu6k5VVuz+wv/bHh3Hum1+M961XkcUqqfWFiXUB+16OyB9EXNoq2xTdajq/1do9FBurl1P4ScX6uGpopZ6QsIVvKNKD0eDQo5uNXKjsg/T1WMJbVcdk3FlOxUS/PkceYrMj73Q3yfKVkErZbbzqt8lXVDwv/gtx+ZaRIwLPcydQ5lDiIZ+JcMrQRla/qEE+vofRYKAuCORSUyqgkq9sYOlT2lUVpdQyQCXKVfry6Kwvurwbkw+3ub65qRrt/YFku5VWRR20oFTr+/MDM2OmfTVTGUs12o1wLZWQ++S20TtRbz9tsNq4NlyxIXRv9r6n1JEU9Yqi69rOSgi8rgLMEVZHr06zueB6+ytLFUyXhuW3Ofv2+ncq1oaWBM+4iyyyV8f/g6uVTymOPU5nbwxMKrM7Mrh/ZkUJVlaaZ5r+CnZXE7L3G19ISxJfZjBW8CxbiMvKyN8leLfLS98he7Td07vgt
Rw9cvG8Cxyp05SXY